A national multicenter study on initial antiviral treatment preferences on chronic hepatitis B: Entecavir versus Tenofovir disoproxil fumarate

dc.contributor.authorYamazhan, Tansu
dc.contributor.authorZerdali, Esra
dc.contributor.authorOnlen, Yusuf
dc.contributor.authorTosun, Selma
dc.contributor.authorGunal, Ozgur
dc.contributor.authorBatirel, Ayse
dc.contributor.authorHasanoglu, Imran
dc.date.accessioned2025-01-27T21:07:34Z
dc.date.available2025-01-27T21:07:34Z
dc.date.issued2024
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.descriptionEuropean-Association-for-the-Study-of-the-Liver Congress (EASL) -- JUN 05-08, 2024 -- Milan, ITALY
dc.description.abstract[Anstract Not Available]
dc.description.sponsorshipEuropean Assoc Study Liver
dc.identifier.endpageS805
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.startpageS805
dc.identifier.urihttps://hdl.handle.net/20.500.12428/28107
dc.identifier.volume80
dc.identifier.wosWOS:001278309403182
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Hepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.titleA national multicenter study on initial antiviral treatment preferences on chronic hepatitis B: Entecavir versus Tenofovir disoproxil fumarate
dc.typeConference Object

Dosyalar